Potential for Pharmacy-Public Health Collaborations Using Pharmacy-Based Point-of-Care Testing Services for Infectious Diseases

Journal of Public Health Management and Practice

Volumn 23, Issue 6, 2017, Pages 593-600

  Gubbins, Paul O ^a   Klepser, Michael E ^b   Adams, Alex J ^c   Jacobs, David M ^d   Percival, Kelly M ^e   Tallman, Gregory B ^f  

^a MISSOURI STATE UNIVERSITY   (United States)

^b FERRIS STATE UNIVERSITY   (United States)

^c Idaho Board of Nursing   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

^e DRAKE UNIVERSITY   (United States)

^f OREGON STATE UNIVERSITY   (United States)

Author keywords

CLIA waived tests; influenza; pharmacy; point of care test; streptococcal pharyngitis

Indexed keywords

CLINICAL LABORATORY SERVICE; COMMUNICABLE DISEASE; COOPERATION; HUMAN; PHARMACY; POINT OF CARE TESTING; PROCEDURES; PUBLIC HEALTH; TRENDS;

CLINICAL LABORATORY SERVICES; COMMUNICABLE DISEASES; COMMUNITY PHARMACY SERVICES; COOPERATIVE BEHAVIOR; HUMANS; POINT-OF-CARE TESTING; PUBLIC HEALTH;

EID: 85006448655     PISSN: 10784659     EISSN: 15505022     Source Type: Journal    
DOI: 10.1097/PHH.0000000000000482     Document Type: Article

References (38)

1. The White House. Executive order combating antibiotic-resistant bacteria. https://www.whitehouse.gov/the-press-office/2014/ 09/18/executive-order-combating-antibiotic-resistant-bacteria. Published September 18, 2014. Accessed April 2, 2016.
2. Weber NC, Klepser ME, Akers JM, Klepser DG, Adams AJ. Use of CLIA-waived point-of-care tests for infectious diseases in community pharmacies in the United States. Exp Rev Mol Diagn. 2016;16:253-264.
3. Giberson S, Yoder S, Lee MP. Improving Patient and Health System Outcomes Through Advanced Pharmacy Practice: a Report to the U.S. Surgeon General. Rockville, MD: Office of the Chief Pharmacist, US Public Health Service; 2011.
4. Roberts GE, Rubin SE, Smith JK, Adams AJ, Klepser DG. Public health perceptions of community pharmacy partnership opportunities. J Public Health Manag Pract. 2015;21:413-415.
5. Adams AJ, Klepser M, Klepser D. Physician-pharmacist collaborative practice agreements: a strategy to improve adherence to evidence-based guidelines. Evid Based Med Public Health. 2015;1:e923.
6. Rubin SE, Schulman RM, Roszak AR, Herrmann J, Patel A, Koonin LM. Leveraging partnerships among community pharmacists, pharmacies, and health departments to improve pandemic influenza response. Biosecur Bioterror. 2014;12:76-84.
7. Gubbins PO, KlepserME, Dering-Anderson AM, et al. Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy. J AmPharm Assoc. 2014;54:163-171.
8. Centers for Disease Control and Prevention. Good laboratory practices for waived testing sites; survey findings from testing sites holding a certificate of waiver under the Clinical Laboratory Improvement Amendments of 1988 and recommendations for promoting quality testing. MMWR Recomm Rep. 2005;54(RR-13): 1-22.
9. Bose ME, Sasman A, Mei H, et al. Analytical reactivity of 13 commercially available rapid influenza diagnostic tests with H3N2v and recently circulating influenza viruses. Influenza Other Respir Viruses. 2014;8:474-481.
10. Chartrand C, Leeflang MMG, Minion J, Brewer T, Pai M. Accuracy of rapid influenza diagnostic tests: a meta-analysis. Ann Intern Med. 2012;156:500-511.
11. Arora DR, Maheshwari M, Arora B. Rapid point-of-care testing for detection of HIV and clinical monitoring. ISRN AIDS. 2013;2013:287269.
12. Pai NP, Vadnais C, Denkinger C, Engel N, Pai M. Point-of-care testing for infectious diseases: diversity, complexity, and barriers in lowand middle-income countries. PLoS Med. 2012;9:e1001306.
13. Lean WL, Arnup S, Danchin M, Steer AC. Rapid diagnostic tests for group A streptococcal pharyngitis: a meta-analysis. Pediatrics. 2014;134:771-781.
14. Shulman ST, Bisno AL, Clegg HW, et al. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis. 2012;55:1279-1282.
15. Harris AM, Hicks LA, Qaseem A. Appropriate antibiotic use for acute respiratory tract infection in adults: advice for high-value care from the American College of Physicians and the Centers for Disease Control and Prevention. Ann Intern Med. 2016;164:425-434.
16. Smith BD, Jewett A, Drobeniuc J, Kamili S. Rapid diagnostic HCV antibody assays. Antivir Ther. 2012;17:1409-1413.
17. Klepser ME, Adams AJ, Srnis P, Mazzucco M, Klepser DG. U.S. community pharmacies as CLIA-waived facilities: prevalence, dispersion, and impact on patient access to testing. Res Social Adm Pharm. 2016;12(4):614-621.
18. Goad JA, Taitel MS, Fensterheim LE, Cannon AE. Vaccinations administered during off-clinic hours at a national community pharmacy: implications for increasing patient access and convenience. Ann Fam Med. 2013;11:429-436.
19. Gaither CA, Schommer JC, Doucette WR, Kreling DH, Mott DA. 2014 National Pharmacist Workforce Survey: final report of the 2014 national sample survey of the pharmacist workforce to determine contemporary demographic practice characteristics and quality of work-life. http://www.aacp.org/resources/research/ pharmacyworkforcecenter/Documents/FinalReportOfTheNational PharmacistWorkforceStudy2014.pdf. Accessed April 18, 2016.
20. Centers for Disease Control and Prevention. Place of influenza vaccination among adults: United States, 2010-11 influenza season. MMWR Morb Mortal Wkly Rep. 2011;60:781-785.
21. Srivastav A, Santibanez TA, Kahn KE, et al. National early season flu vaccination coverage, United States, November 2014. http://www.cdc.gov/flu/fluvaxview/nifs-estimates-nov2014. htm. Accessed April 12, 2016.
22. Klepser ME, Klepser DG, Dering-Anderson AM, Morse JA, Smith JK, Klepser SA. Effectiveness of a pharmacist-physician collaborative program to manage influenza-like illness. J AmPharm Assoc. 2016;56:14-21.
23. Klepser D, Dering-Anderson A, Morse J, Klepser M, Klepser S, Corn C. Time and motion study of influenza diagnostic testing in a community pharmacy. Innov Pharm. 2014;5(2). Article 159.
24. Klepser DG, Corn CE, Schmidt M, Dering-Anderson AM, Klepser ME. Health care resource utilization and costs for influenza-like illness among Midwestern health plan members. J Manage Care Spec Pharm. 2015;21:568-573.
25. Temte J. Real time surveillance of influenza in ambulatory primary care. Paper presented at: 2014 CSTE Annual Conference. https://cste.confex.com/cste/2014/webprogram/Paper3162.html. Accessed April 12, 2016.
26. Calderon Y, Cowan E, Rhee JY, Brusalis C, Leider J. Counselorbased rapid HIV testing in community pharmacies. AIDS Patient Care STDs. 2013;27:467-473.
27. Weidle PJ, Lecher S, Botts LW, et al. HIV testing in community pharmacies and retail clinics: amodel to expand access to screening for HIV infection. J Am Pharm Assoc. 2014;54:486-492.
28. Lecher SL, Shrestha RK, Botts LW, et al. Cost analysis of a novel HIV testing strategy in community pharmacies and retail clinics. J Am Pharm Assoc. 2015;55:488-492.
29. Darin KM, Klepser ME, Klepser DG, et al. Pharmacist-provided rapid HIV testing in two community pharmacies. J Am Pharm Assoc. 2015;55:81-88.
30. Darin KM, Scarsi KK, Klepser DG, et al. Consumer interest in community pharmacy HIV screening services. J Am Pharm Assoc. 2015;55:67-72.
31. Centers for Disease Control and Prevention. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Morb Mortal Wkly Rep. 2012;61:1-18.
32. Klepser DG, Klepser ME, Dering-Anderson AM, Morse JA, Smith JK, Klepser SA. Antimicrobial stewardship in outpatient settings: community pharmacist-physician collaborative streptococcal pharyngitis management program. J Am Pharm Assoc. 2016;56:323-329.
33. McIsaac WJ, White D, Tannenbaum D, Low DE. A clinical score to reduce unnecessary antibiotic use in patients with sore throat. Can Med Assoc J. 1998;158:75-83.
34. McIsaac WJ, Kellner JD, Aufricht P, Vanjaka A, Low DE. Empirical validation of guidelines for the management of pharyngitis in children and adults. JAMA. 2004;291:1587-1595.
35. Barnett ML, Linder JA. Antibiotic prescribing to adults with sore throat in the United States, 1997-2010. JAMA Intern Med. 2014;174:138-140.
36. Daunais DM, Klepser ME, Ogrin BJ. Assessment of pharmacy students' and licensed pharmacists' perceived knowledge, application, and interpretation regarding rapid diagnostic tests (RDTs) for infectious diseases. Curr Pharm Teach Learn. 2015;7:100-105.
37. Akinwale TP, Adams AJ, Dering-Anderson AM, Klepser ME. Pharmacy-based point-of-care testing for infectious diseases: considerations for the pharmacy curriculum. Curr Pharm Teach Learn. 2015;7:131-136.
38. Huang V, Klepser ME, Gubbins PO, et al.Quantification of curricular content devoted to point-of care testing for infectious diseases in schools and colleges of pharmacy in the United States. Pharm Ed. 2015;15:1-6.